Cargando...
Tocilizumab as a steroid sparing agent for the treatment of Graves' orbitopathy
PURPOSE: To describe the effect of tocilizumab in two patients with thyroid associated orbitopathy (TAO). OBSERVATIONS: We present two patients with TAO who could not tolerate corticosteroids and had a reduction in clinical and laboratory markers of inflammatory activity with subsequent tocilizumab...
Guardado en:
| Publicado en: | Am J Ophthalmol Case Rep |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722155/ https://ncbi.nlm.nih.gov/pubmed/29260102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2017.07.001 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|